-
Je něco špatně v tomto záznamu ?
Evaluation of the Number of Follow-up Surgical Procedures and Time Required for Delayed Breast Reconstruction by Clinical Risk Factors, Type of Oncological Therapy, and Reconstruction Approach
P. Ticha, M. Wu, O. Mestak, A. Sukop
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články
Grantová podpora
AZV 17-29084A
grantová agentura české republiky
NLK
ProQuest Central
od 2002-11-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2003-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2002-11-01 do Před 1 rokem
- MeSH
- estetika MeSH
- lidé MeSH
- mamoplastika * škodlivé účinky metody MeSH
- mastektomie metody MeSH
- nádory prsu * etiologie chirurgie MeSH
- následné studie MeSH
- průřezové studie MeSH
- retrospektivní studie MeSH
- rizikové faktory MeSH
- výsledek terapie MeSH
- Check Tag
- lidé MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND: Breast reconstructive surgery is often a multistage process. The aim was to understand which factors might increase the number of follow-up surgeries and the length of time required to complete the reconstruction process. METHODS: A cross-sectional analysis was performed. Clinical data of 110 patients who underwent delayed postmastectomy breast reconstruction with a 5-year examination period were reviewed retrospectively. Impact of clinical risk factors, oncological therapy, and reconstruction approach on the number of surgeries and the length of required time was analyzed. Mann-Whitney U test and Kruskal-Wallis rank sum test were used. RESULTS: In patients undergoing perioperative hormone therapy, an average of 2.9 surgeries and length of 20.2 months were required compared to 2.3 surgeries and 14.0 months in patients without hormone therapy (P = 0.003; P = 0.005). Previous abdominal surgery was associated with an increased number of breast reconstruction stages of 3.1 per patient (P = 0.056) and a longer reconstruction time of 23.0 months (P = 0.050). Patients undergoing nipple reconstruction or implant revision required an increased number of surgeries (P < 0.001; P = 0.012) and a longer reconstruction time (P = 0.002; P < 0.001). Contralateral breast surgery and flap revision were associated only with an increased number of surgeries (P < 0.001; P < 0.001). CONCLUSION: Perioperative hormone therapy was associated with a significantly higher number of surgeries and duration of time required to complete the reconstruction process. The highest increase in the number of surgeries was in patients with flap revision including anastomosis revision and necrectomy. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22011081
- 003
- CZ-PrNML
- 005
- 20230222110646.0
- 007
- ta
- 008
- 220425s2022 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00266-021-02580-1 $2 doi
- 035 __
- $a (PubMed)34595599
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Tichá, Pavla $u Department of Plastic Surgery, 3rd Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University in Prague, Srobarova 50, Praha 10, 10034, Czech Republic $u Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine, 1651 Page Mill Road, Palo Alto, CA, 94304, USA $7 xx0282380
- 245 10
- $a Evaluation of the Number of Follow-up Surgical Procedures and Time Required for Delayed Breast Reconstruction by Clinical Risk Factors, Type of Oncological Therapy, and Reconstruction Approach / $c P. Ticha, M. Wu, O. Mestak, A. Sukop
- 520 9_
- $a BACKGROUND: Breast reconstructive surgery is often a multistage process. The aim was to understand which factors might increase the number of follow-up surgeries and the length of time required to complete the reconstruction process. METHODS: A cross-sectional analysis was performed. Clinical data of 110 patients who underwent delayed postmastectomy breast reconstruction with a 5-year examination period were reviewed retrospectively. Impact of clinical risk factors, oncological therapy, and reconstruction approach on the number of surgeries and the length of required time was analyzed. Mann-Whitney U test and Kruskal-Wallis rank sum test were used. RESULTS: In patients undergoing perioperative hormone therapy, an average of 2.9 surgeries and length of 20.2 months were required compared to 2.3 surgeries and 14.0 months in patients without hormone therapy (P = 0.003; P = 0.005). Previous abdominal surgery was associated with an increased number of breast reconstruction stages of 3.1 per patient (P = 0.056) and a longer reconstruction time of 23.0 months (P = 0.050). Patients undergoing nipple reconstruction or implant revision required an increased number of surgeries (P < 0.001; P = 0.012) and a longer reconstruction time (P = 0.002; P < 0.001). Contralateral breast surgery and flap revision were associated only with an increased number of surgeries (P < 0.001; P < 0.001). CONCLUSION: Perioperative hormone therapy was associated with a significantly higher number of surgeries and duration of time required to complete the reconstruction process. The highest increase in the number of surgeries was in patients with flap revision including anastomosis revision and necrectomy. LEVEL OF EVIDENCE IV: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .
- 650 12
- $a nádory prsu $x etiologie $x chirurgie $7 D001943
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a estetika $7 D004954
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a následné studie $7 D005500
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a mamoplastika $x škodlivé účinky $x metody $7 D016462
- 650 _2
- $a mastektomie $x metody $7 D008408
- 650 _2
- $a retrospektivní studie $7 D012189
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a výsledek terapie $7 D016896
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Wu, Meagan $u Division of Plastic and Reconstructive Surgery, Department of Surgery, Stanford University School of Medicine, 1651 Page Mill Road, Palo Alto, CA, 94304, USA
- 700 1_
- $a Mestak, Ondrej $u Department of Plastic Surgery, Bulovka Hospital, 1st Medical Faculty of Charles University in Prague, Budinova 2, Prague 8, 14800, Czech Republic
- 700 1_
- $a Sukop, Andrej $u Department of Plastic Surgery, 3rd Faculty of Medicine, University Hospital Kralovske Vinohrady, Charles University in Prague, Srobarova 50, Praha 10, 10034, Czech Republic. andrej@sukop.cz $1 https://orcid.org/0000000159245123
- 773 0_
- $w MED00005691 $t Aesthetic plastic surgery $x 1432-5241 $g Roč. 46, č. 1 (2022), s. 71-82
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/34595599 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20230222110641 $b ABA008
- 999 __
- $a ok $b bmc $g 1788930 $s 1162279
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 46 $c 1 $d 71-82 $e 20210930 $i 1432-5241 $m Aesthetic plastic surgery $n Aesthetic Plast Surg $x MED00005691
- GRA __
- $a AZV 17-29084A $p grantová agentura české republiky
- LZP __
- $a Pubmed-20220425